LIGAND PHARMACEUTICALS INCORPORATED Payments to Acquire Businesses, Gross
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Payments to Acquire Businesses, Gross of $10.40 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2023-11-09
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire businesses, gross for the quarter ending 2020-09-30 was $11.72M, a 1.04% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire businesses, gross for the quarter ending 2019-09-30 was $11.84M.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month |
|---|---|---|---|
| 2023-09-30 | $10.40M 10-Q · filed 2023-11-09 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | ||
| 2020-09-30 | $11.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $26.86M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $15.14M 10-Q · filed 2020-08-07 | ||
| 2019-09-30 | $11.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $11.84M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-07 |